Skip to main content
VYGR
NASDAQ Life Sciences

Alzheimer's Gene Therapy VY1706 Shows Strong Preclinical Safety, Tau Reduction; Voyager Eyes H2 2026 Clinical Trials

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$4.32
Mkt Cap
$250.748M
52W Low
$2.645
52W High
$5.55
52W Position info
63% above low
Off High info
22% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

VYGR sits 63% above its 52-week low of $2.645.

Summary

Voyager Therapeutics presented compelling 3-month GLP toxicology data for VY1706, its investigational tau silencing gene therapy for Alzheimer's disease, at the ASGCT Annual Meeting. The data demonstrated that a single intravenous dose of VY1706 was well tolerated in non-human primates and achieved significant tau protein reductions of up to 64% in key brain regions. This positive preclinical safety and efficacy profile supports the company's timeline for an Investigational New Drug (IND) application in Q2 2026, with first-in-human dosing in Alzheimer's patients anticipated in H2 2026. For a small-cap biotech, this represents a significant de-risking event for a lead candidate in a major disease area, providing a clear path to clinical development. Traders will closely monitor the upcoming IND filing and the commencement of human trials as critical near-term catalysts.

At the time of this announcement, VYGR was trading at $4.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $250.7M. The 52-week trading range was $2.65 to $5.55. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

VYGR - Latest Insights

VYGR
Nov 05, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.69
Real-time Price: $1.61 info
Change: -$0.080 (-5%) info
Market Cap: $99.567M info
VYGR
Oct 21, 2026, 8:09 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $2.15
Real-time Price: $1.61 info
Change: -$0.540 (-25%) info
Market Cap: $99.567M info
VYGR
Oct 21, 2026, 8:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.15
Real-time Price: $1.61 info
Change: -$0.540 (-25%) info
Market Cap: $99.567M info
VYGR
Jul 13, 2026, 8:44 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.54
Real-time Price: $1.61 info
Change: -$1.93 (-55%) info
Market Cap: $99.567M info
VYGR
Jul 13, 2026, 8:01 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.45
Real-time Price: $1.61 info
Change: -$1.84 (-53%) info
Market Cap: $99.567M info